The S100B protein binds to the V-C1-C2 extracellular domain of the RAGE receptor. It should be used as a prognostic marker because its levels can predict the severity and progression of neurological disorders by directly activating pathways that cause neuroinflammation, neuronal loss, and neurodegeneration.